Liu, Hongmei

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy

Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 1,569

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 1,073

Development of a Novel Trans-Lentiviral Vector That Affords Predictable Safety

Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T., & Kappes, J. C. (2000) · Molecular Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 137

Expert consensus on perioperative integrated skincare for noninvasive energy‐based device aesthetic procedures in clinical practice in China

Zhang, C., Song, W., Yu, B., Chen, X., Fan, W., Gao, L., Gu, J., Hao, F., He, W., Ju, Q., et al. (2024) · Journal of the European Academy of Dermatology and Venereology

Dermatologic Treatments and ResearchSkin Protection and Aging

Cited by 16